08/26/2025
8:20 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2025
8:21 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
5:10 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G/A | |
08/13/2025
7:47 PM | Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
3:45 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
1:41 PM | Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G/A | |
06/30/2025
3:36 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G | |
06/25/2025
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
3:26 PM | Chow Gregory K. (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/02/2025
3:27 PM | Chow Gregory K. (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for STRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
10:39 AM | Kynam Capital Management, LP (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G | |
05/08/2025
3:28 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
3:30 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
4:45 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
4:46 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
4:48 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
3:30 PM | Sutro Biopharma (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Sutro Biopharma (Filer)
| Form DEFA14A | |
04/25/2025
3:33 PM | Sutro Biopharma (Filer)
| Form ARS | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G/A | |
04/08/2025
3:03 PM | Pauling David (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/08/2025
3:05 PM | Pauling David (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
3:07 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
3:09 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
3:11 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
3:12 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:32 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SCHEDULE 13G | |
03/13/2025
4:14 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
4:17 PM | Sutro Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
3:14 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:06 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:09 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:12 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:32 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:34 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:40 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:42 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:44 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:57 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:58 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Capital Gains Tax Strategies for Seniors (Ad) Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure.
SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. Click here to see the three strategies and get matched with a financial advisor today. |
02/27/2025
3:30 PM | Sutro Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/10/2024
7:00 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:54 PM | Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
8:34 AM | Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/04/2024
1:09 PM | Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
MarketBeat All Access